Updates on IDHm Gliomas: Current and Emerging Treatments Description:
This session will provide updates on the treatment of IDH-mutant gliomas (IDHm gliomas), focusing on existing and emerging therapies. It will cover the role of IDH inhibitors, challenges in treatment, and the latest clinical research on managing these tumors.
Target Audience: Oncology professionals, neuro-oncologists, and clinicians involved in glioma care. Learning
Objectives: By the end of this program, participants will be able to:
This is non-CE program
Have a login? Login Now
{{vm.loginInfo.errorMessage}}
Forgot your Username or Password?
Register as Guest
Address
Phone
{{slot.Name}}
{{ vm.EventInfo.EventSettings.NoShowPolicy }}